Accumulating evidence suggests that NLRP3 inflammasome plays a pivotal role in the pathogenesis of NAFLD/NASH and controls the maturation and release of IL-1β and IL-18 [14, 15]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.